Scaricare la presentazione
La presentazione è in caricamento. Aspetta per favore
PubblicatoElisa Alessi Modificato 5 anni fa
1
High-Dose Melphalan Plus Thiotepa as Conditioning Regimen before Second Autologous Stem Cell Transplantation for “De Novo” Multiple Myeloma Patients: A Phase II Study Maurizio Musso, Giuseppe Messina, Gianpaolo Marcacci, Alessandra Crescimanno, Giuseppe Console, Daniela Donnarumma, Renato Scalone, Antonio Pinto, Massimo Martino Biology of Blood and Marrow Transplantation Volume 21, Issue 11, Pages (November 2015) DOI: /j.bbmt Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions
2
Figure 1 Day 100 response rates after transplant. PR indicates partial response. Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions
3
Figure 2 Progression-free survival.
Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions
4
Figure 3 Overall survival.
Biology of Blood and Marrow Transplantation , DOI: ( /j.bbmt ) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions
Presentazioni simili
© 2024 SlidePlayer.it Inc.
All rights reserved.